STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

PATH VACCINE SOLUTIONS: Form 990, tax year 2016

View the entire original 990 at ProPublica ↗

Organization
PATH VACCINE SOLUTIONS (EIN 83-0431851)
Tax period
2016-01-01 to 2016-12-31
Filed
2017-11-14
IRS object ID
201703189349305755
Schema version
2016v3.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2017-11-14T12:40:02-06:00ReturnTs
Tax Period End2016-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN521392008PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1GELMAN ROSENBERG & FREEDMANBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line14550 MONTGOMERY AVE SUITE 650NAddressLine1Txt
CityBETHESDACityNm
State AbbreviationMDStateAbbreviationCd
ZIP208142930ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2016-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN830431851EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1PATH VACCINE SOLUTIONSBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlPATHBusinessNameControlTxt
Phone2062853500PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line12201 WESTLAKE AVENUE NO 200AddressLine1Txt
CitySEATTLECityNm
State AbbreviationWAStateAbbreviationCd
ZIP98121ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonOLIVIA D POLIUSPersonNm
Person TitleCHIEF FINANCIAL OFFICERPersonTitleTxt
Phone2062853500PhoneNum
Signature2017-11-14SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Phone3019519090PhoneNum

Filing Security Information FilingSecurityInformation

IP Address IPAddress

FieldValueIRS element (for citing)
I Pv4 Address75.103.231.202IPv4AddressTxt
FieldValueIRS element (for citing)
IP2017-11-14IPDt
IP Tm13:39:37IPTm
IP TimezoneESIPTimezoneCd
Filing License TypePFilingLicenseTypeCd
At Submission Creation Device Id24E2B1EDDFB7997E904F8C8AA54720A5F314F67AAtSubmissionCreationDeviceId
At Submission Filing Device Id1C84E1F40D0AB4F75A6C29AABE8087358D4F1C89AtSubmissionFilingDeviceId
FieldValueIRS element (for citing)
Tax2016TaxYr
Build TS2017-02-10 21:41:12ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerOLIVIA D POLIUSPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line12201 WESTLAKE AVENUE NO 200AddressLine1Txt
CitySEATTLECityNm
State AbbreviationWAStateAbbreviationCd
ZIP98121ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$30,037,748GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.PATH.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2006FormationYr
Legal Domicile StateWALegalDomicileStateCd
Activity Or MissionSEE PART III, LINE 1.ActivityOrMissionDesc
Voting Members Governing Body7VotingMembersGoverningBodyCnt
Voting Members Independent2VotingMembersIndependentCnt
Total Employee0TotalEmployeeCnt
Total Volunteers0TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$45,999,268PYContributionsGrantsAmt
CY Contributions Grants$4,727,165CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$733,017PYInvestmentIncomeAmt
CY Investment Income$1,239,778CYInvestmentIncomeAmt
PY Other Revenue$2,587PYOtherRevenueAmt
CY Other Revenue$23,560CYOtherRevenueAmt
PY Total Revenue$46,734,872PYTotalRevenueAmt
CY Total Revenue$5,990,503CYTotalRevenueAmt
PY Grants And Similar Paid$28,397,080PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$29,855,678CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$0PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$0CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$9,999,989PYOtherExpensesAmt
CY Other Expenses$12,217,095CYOtherExpensesAmt
PY Total Expenses$38,397,069PYTotalExpensesAmt
CY Total Expenses$42,072,773CYTotalExpensesAmt
PY Revenues Less Expenses$8,337,803PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$36,082,270CYRevenuesLessExpensesAmt
Total Assets BOY$150,830,465TotalAssetsBOYAmt
Total Assets EOY$107,465,507TotalAssetsEOYAmt
Total Liabilities BOY$4,059,847TotalLiabilitiesBOYAmt
Total Liabilities EOY$15,803,401TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$146,770,618NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$91,662,106NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE MISSION OF PATH VACCINE SOLUTIONS (PVS) IS TO IMPROVE THE HEALTH OF CHILDREN IN LOW-INCOME COUNTRIES BY ACCELERATING THE DEVELOPMENT OF VACCINES THAT WILL BE EFFECTIVE AND AFFORDABLE FOR THOSE WHO NEED THEM MOST. FROM INITIAL DISCOVERY THROUGH CLINICAL TRIALS, PVS WORKS WITH COMMERCIAL PARTNERS, SUCH AS VACCINE MANUFACTURERS AND BIOTECHNOLOGY FIRMS, AND NONPROFIT PARTNERS, SUCH AS UNIVERSITIES AND RESEARCH INSTITUTIONS, TO SHORTEN THE TIMELINE FOR VACCINE DEVELOPMENT.PVS WORKS WITH PARTNERS TO DEVELOP NEW VACCINES BY PROVIDING FUNDING AND EXPERTISE IN PRECLINICAL DEVELOPMENT, MANUFACTURING, AND CLINICAL DEVELOPMENT, WITH A FOCUS ON LOW-RESOURCE COUNTRIES. IN RETURN, PARTNERS AGREE TO TERMS THAT HELP ENSURE THE RESULTING PRODUCTS ARE AFFORDABLE AND AVAILABLE IN DEVELOPING COUNTRIES.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$42,072,773ExpenseAmt
Grant$29,855,678GrantAmt
DescPVS WORKS TO PREVENT DEATH AND DISEASE CAUSED BY DIARRHEA, PNEUMONIA, INFLUENZA, RESPIRATORY SYNCYTIAL VIRUS, AND POLIO AMONG CHILDREN AROUND THE WORLD. WE ACCELERATE THE DEVELOPMENT OF SAFE, EFFICACIOUS, AND AFFORDABLE VACCINES IN PARTNERSHIP WITH PUBLIC AND PRIVATE GROUPS. IN 2016, PVS CONTINUED OUR FIGHT AGAINST DIARRHEAL DISEASES, THE SECOND LEADING CAUSE OF DEATH AMONG CHILDREN IN LOW-INCOME COUNTRIES. TO COMBAT ROTAVIRUS, A MAJOR CAUSE OF SEVERE DIARRHEA, WE CONTINUED TO PARTNER WITH SIIPL TO STUDY A VACCINE THAT MAY REMAIN STABLE AND POTENT EVEN DURING EXTENDED PERIODS WITHOUT REFRIGERATION, ENABLING WIDER USE IN REMOTE COMMUNITIES. WE CONDUCTED A PHASE 3 EFFICACY STUDY OF THE VACCINE, AS WELL AS A STUDY TO EXAMINE CLINICAL LOT CONSISTENCY AND POTENTIAL INTERFERENCE WITH ROUTINE VACCINES. SIIPL SUBMITTED PRIMARY DATA FROM THE EFFICACY STUDY TO THE INDIAN REGULATORY AUTHORITIES, AND THE VACCINE ACHIEVED LICENSURE IN DECEMBER 2016. IN ADDITION, ROTAVAC, ANOTHER INDIAN-MADE VACCINE DEVELOPED WITH PATH SUPPORT, BEGAN A PHASED ROLLOUT IN INDIA'S NATIONAL IMMUNIZATION PROGRAM IN MARCH 2016. [ROTAVAC IS A REGISTERED TRADEMARK OF BHARAT BIOTECH.]WE ALSO CONTINUED TO CONDUCT EARLY-STAGE CLINICAL TRIALS OF VACCINE CANDIDATES THAT MAY PROVIDE PROTECTION AGAINST ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC) AND SHIGELLA, LEADING CAUSES OF BACTERIAL DIARRHEAL ILLNESS. IN ADDITION, WE HOSTED THE FIRST INTERNATIONAL VACCINES AGAINST SHIGELLA AND ETEC (VASE) CONFERENCE JUNE 28 TO 30, 2016, IN WASHINGTON, DC. THE MEETING BROUGHT TOGETHER MORE THAN 250 SCIENTISTS, PUBLIC HEALTH PROFESSIONALS, IMMUNIZATION LEADERS, VACCINE INDUSTRY REPRESENTATIVES, DONORS, AND OTHER EXPERTS FROM APPROXIMATELY 30 COUNTRIES. THE AGENDA FEATURED 23 ABSTRACT-BASED ORAL PRESENTATIONS AND 32 ABSTRACT-BASED POSTER PRESENTATIONS, AND THE CONFERENCE HELPED MAINTAIN THE MOMENTUM FOR SHIGELLA AND ETEC VACCINE RESEARCH AND DEVELOPMENT ACROSS THE ENTERIC VACCINE FIELD.WE ALSO ADVANCED DEVELOPMENT OF LOW-COST VACCINE CANDIDATES TO PROTECT CHILDREN AGAINST PNEUMOCOCCAL BACTERIA, THE TOP CAUSE OF SEVERE CHILDHOOD PNEUMONIA. IN THE GAMBIA, FOR INSTANCE, WE EVALUATED A PNEUMOCOCCAL CONJUGATE VACCINE (PCV-10) CANDIDATE DESIGNED TO BE AFFORDABLE AND TO PROVIDE PROTECTION AGAINST THE TEN BACTERIAL SEROTYPES THAT CAUSE THE MOST CASES OF INVASIVE PNEUMOCOCCAL DISEASE IN AFRICA AND ASIA. IN KENYA, WE STUDIED A VACCINE CANDIDATE WITH THE POTENTIAL TO PROVIDE LOW-COST, BROAD PROTECTION ACROSS MANY SEROTYPES.Desc
Total Program Service Expenses$42,072,773TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Temp Or Permanent Endowments0TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other Liabilities0ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (1)ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign OfficeYes (1)ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With Officer Ent0BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document0IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Employee0EmployeeCnt
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members7GoverningBodyVotingMembersCnt
Independent Voting Member2IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEO0CompensationProcessCEOInd
Compensation Process Other0CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1OLIVIA POLIUS CHIEF FINANCIAL OFFICERBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone2062853500PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line12201 WESTLAKE AVE SUITE 200AddressLine1Txt
CitySEATTLECityNm
State AbbreviationWAStateAbbreviationCd
ZIP98121ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (8 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmt
STEPHEN B DAVIS
CHAIR AND PRESIDENT1.0039.00Yes (X)Yes (X)$0$623,273$62,041
PENNY HEATON
VICE CHAIR1.000.00Yes (X)Yes (X)$0$0$0
OLIVIA D POLIUS
TREASURER1.0039.00Yes (X)Yes (X)$0$303,385$48,805
DANIEL LASTER
SECRETARY1.0039.00Yes (X)Yes (X)$0$304,582$42,894
AMIE E BATSON
DIRECTOR1.0039.00Yes (X)$0$293,566$26,850
DAVID C KASLOW
DIRECTOR1.0039.00Yes (X)$0$354,854$63,492
CHRIS KARP
DIRECTOR1.000.00Yes (X)$0$0$0
DAVID A ALLI
SECRETARY (UNTIL 05/2016)20.0020.00Yes (X)$0$85,148$10,994
FieldValueIRS element (for citing)
Total Reportable Comp From Org$0TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$1,964,808TotReportableCompRltdOrgAmt
Total Other Compensation$255,076TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K0IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp

Contractor Name ContractorName

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1NORTHERN TRUSTBusinessNameLine1Txt

Contractor Address ContractorAddress

US Address USAddress

FieldValueIRS element (for citing)
Address Line150 S LASALLE STAddressLine1Txt
CityCHICAGOCityNm
State AbbreviationILStateAbbreviationCd
ZIP60675ZIPCd
FieldValueIRS element (for citing)
ServicesASSET MANAGEMENTServicesDesc
Compensation$201,668CompensationAmt
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K1CntrctRcvdGreaterThan100KCnt
Related Organizations$282,029RelatedOrganizationsAmt
All Other Contributions$4,445,136AllOtherContributionsAmt
Total Contributions$4,727,165TotalContributionsAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,023,342TotalRevenueColumnAmt
Exclusion$1,023,342ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$24,263,681SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$24,047,245SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$216,436SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$216,436TotalRevenueColumnAmt
Exclusion$216,436ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtExclusionExclusionAmt
OTHER REIMBURSEMENTS900099$12,560$12,560
MISCELLANEOUS900099$11,000$11,000
FieldValueIRS element (for citing)
Other Revenue Total$23,560OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$5,990,503TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$1,263,338ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$22,086,517TotalAmt
Program Services$22,086,517ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$7,769,161TotalAmt
Program Services$7,769,161ProgramServicesAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$8,629TotalAmt
Program Services$8,629ProgramServicesAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$201,668TotalAmt
Program Services$201,668ProgramServicesAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$470,985TotalAmt
Program Services$470,985ProgramServicesAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$5,731TotalAmt
Program Services$5,731ProgramServicesAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$223,044TotalAmt
Program Services$223,044ProgramServicesAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$8,137TotalAmt
Program Services$8,137ProgramServicesAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$9,738TotalAmt
Program Services$9,738ProgramServicesAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$1,644,562TotalAmt
Program Services$1,644,562ProgramServicesAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$325,150TotalAmt
Program Services$325,150ProgramServicesAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$64,306TotalAmt
Program Services$64,306ProgramServicesAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$124,965TotalAmt
Program Services$124,965ProgramServicesAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmt
SUBCONTRACTORS$9,012,149$9,012,149
STORAGE$43,448$43,448
LAB SUPPLIES$38,955$38,955
EQUIPMENT R&M$22,611$22,611

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$13,017TotalAmt
Program Services$13,017ProgramServicesAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$42,072,773TotalAmt
Program Services$42,072,773ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$17,554,485BOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$59,593,963BOYAmt
EOY$32,558,748EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$168,331BOYAmt
EOY$202,886EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
EOY$70EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$234,275LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$191,510LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$100,337BOYAmt
EOY$42,765EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$73,413,349BOYAmt
EOY$74,661,038EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$150,830,465BOYAmt
EOY$107,465,507EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$4,059,847BOYAmt
EOY$15,803,401EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$4,059,847BOYAmt
EOY$15,803,401EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$18,107BOYAmt
EOY$18,107EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$146,752,511BOYAmt
EOY$91,643,999EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$146,770,618BOYAmt
EOY$91,662,106EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$150,830,465BOYAmt
EOY$107,465,507EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss-$36,082,270ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$126,199NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets-$19,152,441OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Supporting Organization509a3Yes (X)SupportingOrganization509a3Ind
Supporting Org Type1Yes (X)SupportingOrgType1Ind
Supported Organizations1SupportedOrganizationsCnt

Supported Org Information SupportedOrgInformationGrp

Supported Organization Name SupportedOrganizationName

FieldValueIRS element (for citing)
Business Name Line1PATHBusinessNameLine1Txt
FieldValueIRS element (for citing)
EIN911157127EIN
Organization Type7OrganizationTypeCd
Governing Document ListedYes (1)GoverningDocumentListedInd
Support$42,072,773SupportAmt
Other Support$0OtherSupportAmt
FieldValueIRS element (for citing)
Supported Organizations Total1SupportedOrganizationsTotalCnt
Support Sum$42,072,773SupportSumAmt
Other Support Sum$0OtherSupportSumAmt

Form990 Sch A Supporting Org Form990SchASupportingOrgGrp

FieldValueIRS element (for citing)
Listed By Name Governing DocYes (1)ListedByNameGoverningDocInd
Suprt Org No IRS Determination0SuprtOrgNoIRSDeterminationInd
Supported Org Section C4560SupportedOrgSectionC456Ind
Supported Org Not Organized US0SupportedOrgNotOrganizedUSInd
Organization Change Suprt Org0OrganizationChangeSuprtOrgInd
Support Non Supported Org0SupportNonSupportedOrgInd
Payment Substantial Contribtr0PaymentSubstantialContribtrInd
Loan Disqualified Person0LoanDisqualifiedPersonInd
Controlled Disqualified Prsn0ControlledDisqualifiedPrsnInd
Disqualified Prsn Controll Int0DisqualifiedPrsnControllIntInd
Disqualified Prsn Ownr Int0DisqualifiedPrsnOwnrIntInd
Excess Business Holdings Rules0ExcessBusinessHoldingsRulesInd
Contribution Controller0ContributionControllerInd
Contribution Family0ContributionFamilyInd
Contribution35 Controlled0Contribution35ControlledInd

Form990 Sch A Type1 Suprt Org Form990SchAType1SuprtOrgGrp

FieldValueIRS element (for citing)
Power Appoint Majority Dir TrstYes (1)PowerAppointMajorityDirTrstInd
Operate Benefit Non Suprt Org0OperateBenefitNonSuprtOrgInd

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$234,275OtherCostOrOtherBasisAmt
Depreciation$191,510DepreciationAmt
Book Value$42,765BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$42,765TotalBookValueLandBuildingsAmt

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (13 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
EAST ASIA AND THE PACIFIC00PROGRAM SERVICESESSENTIAL MEDICINE$189,968
EAST ASIA AND THE PACIFIC00GRANTMAKING$237,309
EUROPE00PROGRAM SERVICESESSENTIAL MEDICINE$1,267,343
EUROPE00GRANTMAKING$1,426,409
NORTH AMERICA00PROGRAM SERVICESESSENTIAL MEDICINE$789
SOUTH AMERICA00PROGRAM SERVICESESSENTIAL MEDICINE$8,147
SOUTH AMERICA00GRANTMAKING$100,000
SOUTH ASIA08PROGRAM SERVICESESSENTIAL MEDICINE$1,341,689
SOUTH ASIA00GRANTMAKING$4,771,246
SUB-SAHARAN AFRICA01PROGRAM SERVICESESSENTIAL MEDICINE$1,139,654
SUB-SAHARAN AFRICA00GRANTMAKING$1,234,197
00
00
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees8SubtotalEmployeesCnt
Continutation Total Office0ContinutationTotalOfficeCnt
Continutation Total Employee1ContinutationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee9TotalEmployeeCnt
Subtotal Spent$4,571,654SubtotalSpentAmt
Continuation Spent$7,145,097ContinuationSpentAmt
Total Spent$11,716,751TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (23 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxt
EAST ASIA AND THE PACIFICESSENTIAL MEDICINE$12,327CHECK/WIRE
SOUTH ASIAESSENTIAL MEDICINE$1,895,080CHECK/WIRE
SUB-SAHARAN AFRICAESSENTIAL MEDICINE$50,000CHECK/WIRE
SOUTH ASIAESSENTIAL MEDICINE$228,767CHECK/WIRE
SOUTH AMERICAESSENTIAL MEDICINE$100,000CHECK/WIRE
SOUTH ASIAESSENTIAL MEDICINE$133,504CHECK/WIRE
SOUTH ASIAESSENTIAL MEDICINE$466,542CHECK/WIRE
EAST ASIA AND THE PACIFICESSENTIAL MEDICINE$205,000CHECK/WIRE
SUB-SAHARAN AFRICAESSENTIAL MEDICINE$233,794CHECK/WIRE
SOUTH ASIAESSENTIAL MEDICINE$950,671CHECK/WIRE
EUROPEESSENTIAL MEDICINE$363,500CHECK/WIRE
SOUTH ASIAESSENTIAL MEDICINE$262,406CHECK/WIRE
SOUTH ASIAESSENTIAL MEDICINE$240,904CHECK/WIRE
EUROPEESSENTIAL MEDICINE$664,360CHECK/WIRE
EAST ASIA AND THE PACIFICESSENTIAL MEDICINE$19,982CHECK/WIRE
EUROPEESSENTIAL MEDICINE$312,442CHECK/WIRE
SOUTH ASIAESSENTIAL MEDICINE$593,372CHECK/WIRE
SUB-SAHARAN AFRICAESSENTIAL MEDICINE$308,179CHECK/WIRE
EUROPEESSENTIAL MEDICINE$297,240CHECK/WIRE
EUROPEESSENTIAL MEDICINE$63,867CHECK/WIRE
SUB-SAHARAN AFRICAESSENTIAL MEDICINE$361,053CHECK/WIRE
SUB-SAHARAN AFRICAESSENTIAL MEDICINE$281,171CHECK/WIRE
EUROPEESSENTIAL MEDICINE-$275,000CHECK/WIRE
FieldValueIRS element (for citing)
Total501c3 Org20Total501c3OrgCnt
Total Other Org3TotalOtherOrgCnt
Transfer To Foreign CorpYes (1)TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationPVS PERFORMS RISK-BASED MONITORING OF SUBRECIPIENTS. POLICIES AND PROCEDURES ARE IN PLACE THAT GUIDE PROJECT TEAMS' FINANCIAL AND TECHNICAL MONITORING OF SUBRECIPIENTS. TO PROVIDE THE MONITORING REQUIRED BY FUNDERS AND TO ENSURE GOOD STEWARDSHIP OF EVERY PROJECT, PVS USES RISK ASSESSMENTS, REPORTING, SITE VISITS, REGULAR CONTACT, OR OTHER MEANS TO PROVIDE RESPONSIBLE ASSURANCE THAT THE SUBRECIPIENT ADMINISTERS FUNDS IN COMPLIANCE WITH LAWS, REGULATIONS, AND PRIME AWARD TERMS, AND ACHIEVES PERFORMANCE GOALS.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (23 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxtAddress Line2USAddress/AddressLine2Txt
AFFINIVAX INC
190 GRANT STREETLEXINGTONMA02420464701432N/A$172,067PRODUCT DEVELOPMENT
BOSTON CHILDREN'S HOSPITAL
300 LONGWOOD AVENUEBOSTONMA02115042774441501(C)(3)$174,830PRODUCT DEVELOPMENT
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUECINCINNATIOH45229310833936501(C)(3)$86,603PRODUCT DEVELOPMENT
FAMILY HEALTH INTERNATIONAL 360
FHI 360 HEADQUARTERS 359 BLACKWELLDURHAMNC27701237413005501(C)(3)$99,476PRODUCT DEVELOPMENTST SUITE 200
FINA BIOSOLUTIONS LLC
9430 KEY WEST AVE SUITE 200ROCKVILLEMD20850205448275N/A$52,917PRODUCT DEVELOPMENT
HARVARD UNIVERSITY SCHOOL OF PUBLIC HEALTH
INTERNATIONAL HEALTH 677 HUNTINGTONBOSTONMA02115042103580501(C)(3)$38,326PRODUCT DEVELOPMENTAVENUE
HENRY M JACKSON FOUNDATION
FOR THE ADVANCEMENT OF MILITARYBETHESDAMD20814521317896501(C)(3)$466,840PRODUCT DEVELOPMENTMEDICINE 4301 JONES BRIDGE ROAD ROO
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1428 MADISON AVENUENEW YORKNY10029136171197501(C)(3)$600,000PRODUCT DEVELOPMENT
INFECTIOUS DISEASE RESEARCH INSTITUTE
1616 EASTLAKE AVE E SUITE 400SEATTLEWA98102911608978501(C)(3)$1,454,597PRODUCT DEVELOPMENT
JHU BLOOMBERG SCHOOL OF PUBLIC HEALTH
615 N WOLFE STREETBALTIMOREMD21205131687001501(C)(3)$254,007PRODUCT DEVELOPMENT
JOHNS HOPKINS UNIVERSITY
OFFICE OF RESEARCH ADMINISTRATIONBALTIMOREMD21205131687001501(C)(3)$561,271PRODUCT DEVELOPMENT615 N WOLFE STREET W1100
LANKENAU INSTITUTE FOR MEDICAL RESEARCH
100 LANCASTER AVEWYNNEWOODPA19096232175659501(C)(3)$58,334PRODUCT DEVELOPMENT
SABIN VACCINE INSTITUTE
2000 PENNSYLVANIA AVENUE SUITE 7100WASHINGTONDC20006061389829501(C)(3)$100,000PRODUCT DEVELOPMENT7100
TULANE EDUCATIONAL FUND
1430 TULANE AVENUE TB-32NEW ORLEANSLA701122632720423889501(C)(3)$19,800PRODUCT DEVELOPMENT
UNITED STATES NAVAL MEDICAL RESEARCH CENTER
503 ROBERT GRANT AVESILVER SPRINGMD209107500470100048GOV$379,450PRODUCT DEVELOPMENT
UNIVERSITY OF ALABAMA AT BIRMINGHAM
701 20TH STREET SOUTH AB 1170BIRMINGHAMAL35294636005396501(C)(3)$200,000PRODUCT DEVELOPMENT
UNIVERSITY OF FLORIDA
219 GRINTER HALL PO BOX 115500GAINESVILLEFL326115500596002052501(C)(3)$41,325PRODUCT DEVELOPMENT
UNIVERSITY OF MARYLAND BALTIMORE
PO BOX 41428BALTIMOREMD212036428526002033501(C)(3)$770,526PRODUCT DEVELOPMENT
UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE CENTER FOR VACCINE DEVELOPMENT
685 WEST BALTIMORE STREET ROOM 480BALTIMOREMD21201526002033501(C)(3)$260,591PRODUCT DEVELOPMENT
WALTER REED ARMY INSTITUTE OF RESEARCH
503 ROBERT GRANT DRIVESILVER SPRINGMD209107500520664528GOV$632,903PRODUCT DEVELOPMENT
WASHINGTON UNIVERSITY IN ST LOUIS
ONE BROOKINGS DRIVE CAMPUS BOX 1054ST LOUISMO63130430653611501(C)(3)$161,862PRODUCT DEVELOPMENT1054
PATH
2201 WESTLAKE AVE SUITE 200SEATTLEWA98121911157127501(C)(3)$15,502,397PRODUCT DEVELOPMENT
BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA
701 20TH STREET SOUTH AB 1170BIRMINGHAMAL352940111636001138501(C)(3)-$6,255PRODUCT DEVELOPMENT
FieldValueIRS element (for citing)
Total501c3 Org21Total501c3OrgCnt
Total Other Org2TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationPVS PERFORMS RISK-BASED MONITORING OF SUBRECIPIENTS. POLICIES AND PROCEDURES ARE IN PLACE THAT GUIDE PROJECT TEAMS' FINANCIAL AND TECHNICAL MONITORING OF SUBRECIPIENTS. TO PROVIDE THE MONITORING REQUIRED BY FUNDERS AND TO ENSURE GOOD STEWARDSHIP OF EVERY PROJECT, PVS USES RISK ASSESSMENTS, REPORTING, SITE VISITS, REGULAR CONTACT, OR OTHER MEANS TO PROVIDE RESPONSIBLE ASSURANCE THAT THE SUBRECIPIENT ADMINISTERS FUNDS IN COMPLIANCE WITH LAWS, REGULATIONS, AND PRIME AWARD TERMS, AND ACHIEVES PERFORMANCE GOALS.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (5 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
STEPHEN B DAVIS
CHAIR AND PRESIDENT$0$475,514$0$143,338$0$4,421$0$31,800$0$30,241$0$685,314$0$0
OLIVIA D POLIUS
TREASURER$0$301,435$0$0$0$1,950$0$31,541$0$17,264$0$352,190$0$0
DANIEL LASTER
SECRETARY$0$302,682$0$0$0$1,900$0$31,800$0$11,094$0$347,476$0$0
AMIE E BATSON
DIRECTOR$0$292,301$0$0$0$1,265$0$26,034$0$816$0$320,416$0$0
DAVID C KASLOW
DIRECTOR$0$350,433$0$0$0$4,421$0$31,800$0$31,692$0$418,346$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 3FormAndLineReferenceDesc
ExplanationPVS RELIES ON A RELATED ORGANIZATION, PATH, TO DETERMINE COMPENSATION. PATH USES THE FOLLOWING TO ESTABLISH COMPENSATION OF THE EXECUTIVE DIRECTOR: - COMPENSATION COMMITTEE - INDEPENDENT COMPENSATION CONSULTANT - COMPENSATION SURVEY OR STUDY - APPROVAL BY THE BOARD OR COMPENSATION COMMITTEEExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION B, LINE 11BTHE FORM 990 WAS PREPARED BY AN OUTSIDE ACCOUNTING FIRM (GELMAN, ROSENBERG & FREEDMAN CPAS) USING INFORMATION PROVIDED BY PATH ACCOUNTING SERVICES STAFF. PATH SENIOR MANAGEMENT REVIEWED THE DRAFT FORM. A COPY OF THE DRAFT WAS SENT TO PATH'S BOARD OF DIRECTORS FOR COMMENT. AFTER THE COMMENT PERIOD, THE CHIEF FINANCIAL OFFICER SIGNED AND FILED THE RETURN.
FORM 990, PART VI, SECTION B, LINE 12CPVS HAS A WRITTEN CONFLICT OF INTEREST POLICY UNDER WHICH ALL PVS BOARD MEMBERS AND OFFICERS MUST COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM EACH YEAR. PVS DOES NOT HAVE EMPLOYEES. PVS IS A SUPPORTING ORGANIZATION TO PATH WITHIN THE MEANING OF INTERNAL REVIEW CODE SECTION 509(A)(3), AND PVS CONTRACTS WITH PATH FOR MANAGEMENT SERVICES. PATH HAS A WRITTEN CONFLICT OF INTEREST POLICY UNDER WHICH ALL PATH BOARD MEMBERS, OFFICERS, AND STAFF AT HIGHER THAN A DESIGNATED LEVEL MUST COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM EACH YEAR. ALL PVS AND PATH DISCLOSURE FORMS ARE REVIEWED AND KEPT ON FILE. A CONFLICT MANAGEMENT PLAN IS DEVELOPED FOR ANY EMPLOYEE WITH A SIGNIFICANT ACTUAL OR PERCEIVED CONFLICT OF INTEREST.
FORM 990, PART VI, SECTION C, LINE 19PVS'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST; MOST DOCUMENTS ARE ALSO AVAILABLE ONLINE.
FORM 990, PART XI, LINE 9:FROM TIME TO TIME, UNSPENT AWARD FUNDS (OR UNUSED OBLIGATIONS) MAY BE RETURNED TO A FUNDER FOR A VARIETY OF REASONS INCLUDING, BUT NOT LIMITED TO, EARLY TERMINATION OF A PROJECT BY A FUNDER, OR A REDUCTION IN FUNDS REQUIRED TO ACCOMPLISH A PROJECT'S SCOPE OF WORK. -19,152,441.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (3 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdExempt Code SectionExemptCodeSectionTxtPublic Charity StatusPublicCharityStatusTxtDirect Controlling NADirectControllingNACdControlled OrganizationControlledOrganizationIndBusiness Name Line1DirectControllingEntityName/BusinessNameLine1TxtAddress Line1ForeignAddress/AddressLine1TxtCityForeignAddress/CityNmCountryForeignAddress/CountryCdLegal Domicile Foreign CountryLegalDomicileForeignCountryCd
PATH
2201 WESTLAKE AVE SUITE 200SEATTLEWA98121911157127GLOBAL HEALTHWA501(C)(3)LINE 7N/A0
PATH DRUG SOLUTIONS
280 UTAH AVENUE SUITE 250SAN FRANCISCOCA94080943384500DEVELOPMENT & DISTRIBUTION OF SAFE, EFFECTIVE, AND AFFORDABLE MEDICINESCA501(C)(3)LINE 12A, IYes (1)PATH
FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND
EDUCATIONAL AND SCIENTIFIC PROMOTION OF HEALTH501(C)(3)Yes (1)PATH207 ROUTE DE FERNEY 1218 LE GRAND-SGENEVASZSZ
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgYes (1)GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth OrgYes (1)GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org0PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of Facilities0SharingOfFacilitiesInd
Paid Employees Sharing0PaidEmployeesSharingInd
Reimbursement Paid To Other Org0ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd